SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-011056
Filing Date
2020-06-12
Accepted
2020-06-12 09:00:07
Documents
17
Period of Report
2020-06-08
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 35077
2 ex99-1.htm EX-99.1 19081
3 ex99-2.htm EX-99.2 13724
4 ex99-2_001.jpg GRAPHIC 65593
5 ex99-2_002.jpg GRAPHIC 191710
6 ex99-2_003.jpg GRAPHIC 114994
7 ex99-2_004.jpg GRAPHIC 141226
8 ex99-2_005.jpg GRAPHIC 77331
9 ex99-2_006.jpg GRAPHIC 107314
10 ex99-2_007.jpg GRAPHIC 88343
11 ex99-2_008.jpg GRAPHIC 103717
12 ex99-2_009.jpg GRAPHIC 131418
13 ex99-2_010.jpg GRAPHIC 103527
14 ex99-2_011.jpg GRAPHIC 139219
15 ex99-2_012.jpg GRAPHIC 100951
16 ex99-2_013.jpg GRAPHIC 51291
17 ex99-2_014.jpg GRAPHIC 31259
  Complete submission text file 0001493152-20-011056.txt   2064208
Mailing Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080
Business Address 701 GATEWAY BLVD. SUITE 210 SOUTH SAN FRANCISCO CA 94080 650-635-7000
MATEON THERAPEUTICS INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21990 | Film No.: 20959005
SIC: 2834 Pharmaceutical Preparations